Description

4H-1,4-Benzoxazine-4-Acetamide,2,3-Dihydro-2-Methyl-n-(3-Methyl-2-Pyridinyl)-3-Oxo-(9Ci) is a high-purity, advanced pharmaceutical intermediate with a complex heterocyclic structure. This compound is critical for research and development in medicinal chemistry, particularly in the synthesis of novel active pharmaceutical ingredients (APIs). It is primarily sought by pharmaceutical R&D laboratories, fine chemical manufacturers, and academic institutions engaged in drug discovery programs targeting central nervous system and other therapeutic areas.

Application

• Pharmaceutical Intermediate: Key building block in the synthesis of novel drug candidates and active pharmaceutical ingredients (APIs).
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies and lead optimization for new therapeutic agents.
• Organic Synthesis Reference Standard: Serves as a high-purity reference material for analytical method development and validation.
• Biochemical Research: Potential tool compound for investigating biological pathways and enzyme interactions.
• Fine Chemical Production: Intermediate in the multi-step synthesis of complex, high-value specialty chemicals.

Basic Information

Product Name	4H-1,4-Benzoxazine-4-Acetamide,2,3-Dihydro-2-Methyl-n-(3-Methyl-2-Pyridinyl)-3-Oxo-(9Ci)
CAS No.	606119-07-7
Molecular Formula	C₁₇H₁₇N₃O₃
Molecular Weight	311.34 g/mol
Synonyms	2,3-Dihydro-2-methyl-N-(3-methyl-2-pyridinyl)-3-oxo-4H-1,4-benzoxazine-4-acetamide; 4H-1,4-Benzoxazine-4-acetamide, 2,3-dihydro-2-methyl-N-(3-methyl-2-pyridinyl)-3-oxo-; 606119-07-7; 4H-1,4-Benzoxazine-4-acetic acid, 2,3-dihydro-2-methyl-3-oxo-, 2-(3-methyl-2-pyridinyl)hydrazide (9CI); 2-Methyl-2,3-dihydro-3-oxo-N-(3-methylpyridin-2-yl)-4H-1,4-benzoxazine-4-acetamide
EINECS	Contact for details

Quality Control

Our 4H-1,4-Benzoxazine-4-Acetamide,2,3-Dihydro-2-Methyl-n-(3-Methyl-2-Pyridinyl)-3-Oxo-(9Ci) is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods, to ensure it meets the stringent requirements for pharmaceutical R&D. A detailed Certificate of Analysis (COA) is provided with every shipment, documenting all critical quality attributes.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, well-ventilated area at controlled room temperature (15-25°C). The product should be handled under inert atmosphere if prolonged exposure is anticipated to prevent degradation.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.